Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease heparin-induced thrombocytopenia
Symptom C0040053|thrombosis
Sentences 31
PubMedID- 22340251 A rare case of arterial thrombosis due to heparin-induced thrombocytopenia.
PubMedID- 25169901 Progressive, fatal thrombosis associated with heparin-induced thrombocytopenia after cardiac surgery despite "therapeutic" anticoagulation with argatroban: potential role for ptt and act confounding.
PubMedID- 23419837 We report a case of refractory heparin-induced thrombocytopenia with thrombosis (hitt) with prolonged thrombocytopenia and multiple thrombotic complications that failed to improve despite aggressive treatment.
PubMedID- 22382479 Purpose: a case report describing high-dose argatroban for the treatment of heparin-induced thrombocytopenia (hit) with thrombosis and associated considerations in interpreting laboratory monitoring data are presented.
PubMedID- 26149332 Left atrial thrombosis due to heparin-induced thrombocytopenia.
PubMedID- 23533431 thrombosis due to heparin-induced thrombocytopenia (hit) is rare but has a severe prognosis.
PubMedID- 22415004 In view of the interesting evidence that suggests a potential role for bacteria in triggering disorders that have an autoimmune component—e.g., the antiphospholipid syndrome (20) and heparin-induced thrombocytopenia with thrombosis (21)—we wondered whether bacteria might also bind anxa5.
PubMedID- 24299288 heparin-induced thrombocytopenia in a patient with acute thrombosis, acute aortic dissection and acute lower limb ischaemia.
PubMedID- 21083469 Argatroban is a synthetic, small-molecule direct thrombin inhibitor that is approved in the usa, the eu and japan for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (hit), and for anticoagulation of hit patients undergoing pci.
PubMedID- 23424064 Recurrent left atrial and left ventricular thrombosis due to heparin-induced thrombocytopenia: case report and short review.
PubMedID- 24733133 Purpose: the case of an oncology patient who developed heparin-induced thrombocytopenia with thrombosis (hitt) and was treated with argatroban plus catheter-directed thrombolysis (cdt) with alteplase is presented.
PubMedID- 21095367 To our knowledge this is the first report of successful thrombolysis of pulmonary thrombosis due to heparin-induced thrombocytopenia after pulmonary endarterectomy.
PubMedID- 20807654 heparin-induced thrombocytopenia (hit) with thrombosis is the most severe side effect of heparin administration.
PubMedID- 23832870 Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.
PubMedID- 24300023 We describe one such case of rapid-onset, heparin-induced thrombocytopenia with thrombosis that developed in the setting of catheter-directed ablation of atrial fibrillation, several months after a brief exposure to low-molecular-weight heparin.
PubMedID- 22719771 The following case report illustrates an unusual etiologic mechanism for acute myocardial infarction, involving cardiac trauma with subsequent coronary dissection and endothelial disruption, followed by thrombosis in the context of heparin-induced thrombocytopenia.
PubMedID- 24439323 The indications were (1) impaired cardiac function (n = 13); (2) no other prospect for avf or patient refused prosthetic graft implantation (n = 5); (3) severe upper extremity arterial disease or ischemic steal syndrome requiring avf closure (n = 3); (4) venous hypertension with central vein occlusion (n = 2); and (5) repeated avf thrombosis due to heparin-induced thrombocytopenia (n = 1).
PubMedID- 20460351 heparin-induced thrombocytopenia with thrombosis (hitt) is the most severe side effect of heparin administration.
PubMedID- 26062524 Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
PubMedID- 22970706 Argatroban is an intravenous direct thrombin inhibitor currently indicated for the prophylaxis and treatment of thrombosis associated with heparin-induced thrombocytopenia (hit) and for patients at risk of hit undergoing percutaneous coronary intervention (pci).
PubMedID- 22519199 heparin-induced thrombocytopenia with iliacofemoropopliteal thrombosis in a patient operated for colorectal carcinoma liver metastases.
PubMedID- 20460341 Acute myocardial infarction during thrombolysis of mechanical aortic valve thrombosis associated with heparin-induced thrombocytopenia.
PubMedID- 22627957 thrombosis due to heparin-induced thrombocytopenia (hit) occurred during pci, which was completed after switching to argatroban based on the possible hit.
PubMedID- 24766968 thrombosis was attributed to heparin-induced thrombocytopenia if it occurred within 1 week of the positive serologic test.
PubMedID- 21297217 Acute stent thrombosis associated with heparin-induced thrombocytopenia and abciximab-induced profound thrombocytopenia.
PubMedID- 19903167 A portion of these patients will have significant thrombotic complications referred to as hitt (heparin-induced thrombocytopenia with thrombosis).
PubMedID- 21701111 The present case illustrates the possibility of heparin-induced thrombocytopenia associated with catheter-related thrombosis in neurosurgery.
PubMedID- 25980337 He had venous thrombosis due to heparin-induced thrombocytopenia and a right-to-left shunt, likely due to a trans-septal puncture during catheter ablation.
PubMedID- 22893109 We report a case of heparin-induced thrombocytopenia with thrombosis type 2 (hitt 2) that was first complicated by intracerebral hemorrhage (ich) and later by deep venous thrombosis (dvt).
PubMedID- 20504888 Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting.
PubMedID- 21593020 heparin-induced thrombocytopenia with thrombosis (hitt) is a complication of heparin treatment caused by heparin platelet factor 4 (hpf-4) antibodies, leading to platelet activation and hypercoagulability.

Page: 1